Beijing Leadman Biochemistry Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 541.96 million compared to CNY 414.31 million a year ago. Revenue was CNY 541.96 million compared to CNY 414.31 million a year ago.

Net income was CNY 34.47 million compared to CNY 29.06 million a year ago. Basic earnings per share from continuing operations was CNY 0.0634 compared to CNY 0.0673 a year ago. Diluted earnings per share from continuing operations was CNY 0.0634 compared to CNY 0.0673 a year ago.